Ran Nussbaum

Ran Nussbaum

Direttore/Membro del Consiglio presso LB PHARMACEUTICALS INC

Patrimonio netto: 57 960 $ in data 31/10/2026

53 anni
Health Technology
Finance
Health Services

Profilo

Ran Nussbaum is the founder of Pontifax Management Co. Ltd., founded in 2004, serving as Managing Partner.
Mr. Nussbaum is the founder of Pontifax Group, founded in 2004, serving as Managing Partner.
Current jobs include Director at Pontifax Management 2 G.P.
(2007) Ltd., Pontifax (Israel) IV LP, Anaveon AG, Lutris Pharma Ltd., Indapta Therapeutics, Inc., Graviton Bioscience Corp., Orvida Pharma Ltd., and Advisory Committee member at Aliment Capital LLC.
Managing Partner at Pontifax Management 4 Gp 2015 Ltd. Independent Director at LB Pharmaceuticals, Inc. since 2023.
Former jobs include Chairman & Chief Executive Officer at BioMedix, Inc. from 2006 to 2008; Chief Executive Officer at Spearhead, LLC from 2009 to 2010; Chairman at SciSparc Ltd. from 2007 to 2010; Chairman at Spearhead Investments (Bio) Ltd.; Chairman at OCON Medical Ltd.; Director at ArQule, Inc., Bioblast Pharma Ltd., CollPlant Ltd., Nutrinia Ltd., Quiet Therapeutics Ltd., Eloxx Pharmaceuticals Ltd., Fore Biotherapeutics, Inc., N T B Pharma Ltd., Zolex Therapeutics Ltd., Pontifax (Cayman) III LP, Pontifax (Israel) III LP, and SciSparc Ltd. Director at ProtAb Ltd. from 2010 to 2014; Director at Erech Finance Cahalacha Ltd. from 2013 to 2015; Director at CollPlant Biotechnologies Ltd. from 2010 to 2014; Independent Director at Kite Pharma, Inc. from 2014 to 2017; Director at cCAM Biotherapeutics Ltd. from 2012 to 2015; Independent Director at UroGen Pharma Ltd. from 2013 to 2023; Director at Fusimab Ltd. from 2010 to 2014; Director at VBI Vaccines, Inc. from 2017 to 2018; Independent Director at Eloxx Pharmaceuticals, Inc. from 2017 to 2022; Independent Director at Prevail Therapeutics, Inc. from 2018 to 2021; Independent Director at Keros Therapeutics, Inc. from 2023 to 2025.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
15/10/2025 5.250 ( 0,03% ) 57 960 $ 31/10/2026

Posizioni attive di Ran Nussbaum

SocietàPosizioneInizio
LB PHARMACEUTICALS INC Direttore/Membro del Consiglio 01/08/2023
Fondatore 01/01/2004
Pontifax Group
Fondatore 01/12/2004
Pontifax Management 2 G.P. (2007) Ltd.
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ -

Precedenti posizioni note di Ran Nussbaum

SocietàPosizioneFine
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Ran Nussbaum

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

56

Relazioni di 1° grado

39

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private39

Health Technology

Health Technology

Spearhead, LLC

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Spearhead Investments (Bio) Ltd.

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Fusimab Ltd.

Health Technology

Pontifax Group

Pontifax Management 2 G.P. (2007) Ltd.

Health Technology

Health Technology

Finance

Health Technology

Commercial Services

Health Technology

Health Technology

Finance

Finance

Finance

Health Technology

Pontifax Management 4 Gp 2015 Ltd.

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Mercati
  2. Insider
  3. Ran Nussbaum